352PD A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

Annals of Oncology ◽

10.1093/annonc/mdv528.09 ◽

2015 ◽

Vol 26 ◽

pp. ix103 ◽

Author(s):

S. Jiang ◽

J. Xia

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Tumor Infiltrating Lymphocytes ◽

Phase I Clinical Trial ◽

Primary Hepatocellular Carcinoma ◽

Autologous Tumor ◽

Infiltrating Lymphocytes

Download Full-text

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

10.18632/oncotarget.5463 ◽

2015 ◽

Vol 6 (38) ◽

pp. 41339-41349 ◽

Author(s):

Shan-Shan Jiang ◽

Yan Tang ◽

Yao-Jun Zhang ◽

De-Sheng Weng ◽

Zhong-Guo Zhou ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Tumor Infiltrating Lymphocytes ◽

Phase I Clinical Trial ◽

Primary Hepatocellular Carcinoma ◽

Autologous Tumor ◽

Infiltrating Lymphocytes

Download Full-text

531 MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results

European Journal of Cancer ◽

10.1016/s0959-8049(16)30332-x ◽

2015 ◽

Vol 51 ◽

pp. S114 ◽

Author(s):

D. Migliorini ◽

R. Vernet ◽

M.C. Belkouch ◽

P. Luy ◽

S. Blaser ◽

...

Keyword(s):

Clinical Trial ◽

Clinical Outcome ◽

Phase I ◽

Tumor Cells ◽

Phase I Clinical Trial ◽

Autologous Tumor ◽

Cell Technology

Download Full-text

Adoptive Transfer of Autologous Invariant NKT Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial

The Oncologist ◽

10.1002/onco.13899 ◽

2021 ◽

Author(s):

Yao Gao ◽

Jia Guo ◽

Xuli Bao ◽

Fang Xiong ◽

Yanpin Ma ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Adoptive Transfer ◽

Nkt Cells ◽

Phase I Clinical Trial ◽

Advanced Hepatocellular Carcinoma ◽

Invariant Nkt Cells

Download Full-text

Phase I Clinical Trial of Targeted Therapy Using 131I-Hepama-1 mAb in Patients with Hepatocellular Carcinoma

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/1084978042484777 ◽

2004 ◽

Vol 19 (5) ◽

pp. 589-600

Author(s):

Shaoliang Chen ◽

Beilei Li ◽

Hong Xie ◽

Li Xu ◽

Guangjun Niu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Targeted Therapy ◽

Phase I ◽

Phase I Clinical Trial

Download Full-text

Phase I Clinical Trial of Targeted Therapy Using 131I-Hepama-1 mAb in Patients with Hepatocellular Carcinoma

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/cbr.2004.19.589 ◽

2004 ◽

Vol 19 (5) ◽

pp. 589-600 ◽

Author(s):

Shaoliang Chen ◽

Beilei Li ◽

Hong Xie ◽

Li Xu ◽

Guangjun Niu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Targeted Therapy ◽

Phase I ◽

Phase I Clinical Trial

Download Full-text

A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e14655 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e14655-e14655

Author(s):

J. Yi ◽

H. Ahn ◽

S. Lee ◽

J. Uhm ◽

J. Lee ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Phase I Clinical Trial ◽

Advanced Hepatocellular Carcinoma

Download Full-text

Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma

World Journal of Gastroenterology ◽

10.3748/wjg.v10.i8.1146 ◽

2004 ◽

Vol 10 (8) ◽

pp. 1146 ◽

Author(s):

Ming Shi ◽

Bing Zhang ◽

Zi-Rong Tang ◽

Zhou-Yun Lei ◽

Hui-Fen Wang ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Cell Therapy ◽

Phase I ◽

Killer Cell ◽

Primary Hepatocellular Carcinoma ◽

Download Full-text

Abstract 5585: Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma

10.1158/1538-7445.am2012-5585 ◽

2012 ◽

Author(s):

Jia Jinbin ◽

Xiao Zhen-Yu ◽

Chen Xiao-Ping

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Continuous Infusion ◽

Phase I Clinical Trial ◽

Advanced Hepatocellular Carcinoma

Download Full-text

Preliminary Results of Hepatocellular Carcinoma Patients Treated by Talaporfin Sodium and Interstitial Light Emitting Diodes – A Phase I Clinical Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-200609001-00434 ◽

2006 ◽

Vol 101 ◽

pp. S190

Author(s):

Wei-Chen Lee ◽

Sheng-Nan Lu ◽

Yi-Hong Chou ◽

Jeng-Hwei Tseng ◽

Jing-Houng Wang ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Light Emitting Diodes ◽

Phase I Clinical Trial ◽

Light Emitting ◽

Talaporfin Sodium ◽

Preliminary Results

Download Full-text

Expression of Inhibitory Receptors in Natural Killer (CD3−CD56+) Cells and CD3+CD56+ Cells in the Peripheral Blood Lymphocytes and Tumor Infiltrating Lymphocytes in Patients with Primary Hepatocellular Carcinoma

Clinical Immunology ◽

10.1006/clim.2001.5110 ◽

2001 ◽

Vol 101 (3) ◽

pp. 264-269 ◽

Author(s):

Man-Fung Yuen ◽

Suzanne Norris

Keyword(s):

Hepatocellular Carcinoma ◽

Natural Killer ◽

Peripheral Blood ◽

Tumor Infiltrating Lymphocytes ◽

Peripheral Blood Lymphocytes ◽

Primary Hepatocellular Carcinoma ◽

Inhibitory Receptors ◽

Blood Lymphocytes ◽

Infiltrating Lymphocytes

Download Full-text